Scott G, Hewett M L
Department of Botany, University of Cape Town, Private Bag, Rondebosch 7700, South Africa.
J Ethnopharmacol. 2008 Feb 12;115(3):339-60. doi: 10.1016/j.jep.2007.10.020. Epub 2007 Oct 23.
The earliest inhabitants of South Africa are believed to be the Khoi-Khoi and San peoples, whose knowledge of economic botany is extensive. Their ethnomedical practice, based on the plant species indigenous to the region, is an oral tradition and particularly susceptible to disruption. The culture of both peoples has during the past 350 years come under increasing threat of extinction, resulting in the likely loss to science of important ethnomedical knowledge. While written records of Khoi-San traditional medical practice are preserved in English, they mainly cover the period from 1800 onward. Earlier written records do exist, but do not appear to have been adequately screened. The present study was undertaken in order to complete the historical written record by critically examining all potential sources of Khoi and San ethnomedical information, for the years 1650-1800. These sources comprised journals of exploratory expeditions, herbarium specimens, published academic works and archival records associated with the activities of the former Dutch East India Company (VOC) at the Cape. The results of the search show that the VOC had a great interest in Khoi and San traditional medicines and attempted to record this knowledge. The VOC archives in particular represent a largely untapped source of ethnomedical information with potential application in health care, new drug development and intellectual property protection.
南非最早的居民据信是科伊科伊人(Khoi-Khoi)和桑人(San),他们对经济植物学的了解十分广泛。他们基于该地区本土植物物种的民族医学实践是一种口头传统,特别容易受到破坏。在过去的350年里,这两个民族的文化都面临着日益严重的灭绝威胁,导致重要的民族医学知识很可能会从科学领域流失。虽然科伊桑人传统医学实践的书面记录以英文保存,但主要涵盖1800年以后的时期。更早的书面记录确实存在,但似乎没有得到充分筛选。本研究旨在通过批判性地审查1650年至1800年期间所有可能的科伊人和桑人民族医学信息来源,来完善历史书面记录。这些来源包括探索性探险的日志、植物标本馆标本、已发表的学术著作以及与前荷兰东印度公司(VOC)在开普敦的活动相关的档案记录。搜索结果表明,荷兰东印度公司对科伊人和桑人的传统药物非常感兴趣,并试图记录这些知识。特别是荷兰东印度公司的档案代表了一个很大程度上未被开发的民族医学信息来源,在医疗保健、新药开发和知识产权保护方面具有潜在应用价值。